These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 18403767)

  • 1. The challenge of HIV-1 subtype diversity.
    Taylor BS; Sobieszczyk ME; McCutchan FE; Hammer SM
    N Engl J Med; 2008 Apr; 358(15):1590-602. PubMed ID: 18403767
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of HIV-1 pol diversity on drug resistance and its clinical implications.
    Kantor R
    Curr Opin Infect Dis; 2006 Dec; 19(6):594-606. PubMed ID: 17075337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultradeep sequencing of B and non-B HIV-1 subtypes: Viral diversity and drug resistance mutations before and after one month of antiretroviral therapy in naive patients.
    Epaulard O; Signori-Schmuck A; Larrat S; Kulkarni O; Blum MG; Fusillier K; Blanc M; Leclercq P; François O; Morand P
    J Clin Virol; 2017 Oct; 95():13-19. PubMed ID: 28830014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversity, drug resistance, and the epidemic of subtype C HIV-1 in Africa.
    Katzenstein D
    J Infect Dis; 2006 Sep; 194 Suppl 1():S45-50. PubMed ID: 16921472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When do minority drug-resistant HIV-1 variants have a major clinical impact?
    Heneine W
    J Infect Dis; 2010 Mar; 201(5):647-9. PubMed ID: 20102273
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evolution and Diversity of HIV-1].
    Metzner KJ
    Praxis (Bern 1994); 2011 Jan; 100(1):29-35. PubMed ID: 21210358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genetic variability of HIV-1 and its implications.
    Peeters M
    Transfus Clin Biol; 2001 Jun; 8(3):222-5. PubMed ID: 11499964
    [No Abstract]   [Full Text] [Related]  

  • 8. Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?
    Visseaux B; Assoumou L; Mahjoub N; Grude M; Trabaud MA; Raymond S; Wirden M; Morand-Joubert L; Roussel C; Montes B; Bocket L; Fafi-Kremer S; Amiel C; De Monte A; Stefic K; Pallier C; Tumiotto C; Maillard A; Vallet S; Ferre V; Bouvier-Alias M; Dina J; Signori-Schmuck A; Carles MJ; Plantier JC; Meyer L; Descamps D; Chaix ML;
    J Antimicrob Chemother; 2020 Jan; 75(1):183-193. PubMed ID: 31641777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clades of HIV: their origins and clinical significance.
    Stebbing J; Moyle G
    AIDS Rev; 2003; 5(4):205-13. PubMed ID: 15011999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HIV-1 Non-subtype B Workgroup: an international collaboration for the collection and analysis of HIV-1 non-subtype B data.
    Kantor R; Shafer RW; Katzenstein D;
    MedGenMed; 2005 Feb; 7(1):71. PubMed ID: 16369376
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection and significance of minority quasispecies of drug-resistant HIV-1.
    Metzner KJ
    J HIV Ther; 2006 Dec; 11(4):74-81. PubMed ID: 17578210
    [No Abstract]   [Full Text] [Related]  

  • 12. A fossil record of zidovudine resistance in transmitted isolates of HIV-1.
    Kuritzkes DR
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13485-7. PubMed ID: 11717419
    [No Abstract]   [Full Text] [Related]  

  • 13. HIV-1 genetic diversity and genotypic drug susceptibility in the Republic of Georgia.
    Zarandia M; Tsertsvadze T; Carr JK; Nadai Y; Sanchez JL; Nelson AK
    AIDS Res Hum Retroviruses; 2006 May; 22(5):470-6. PubMed ID: 16706626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-treatment drug resistance and HIV-1 genetic diversity in the rural and urban settings of Northwest-Cameroon.
    Fokam J; Takou D; Teto G; Nforbih SE; Kome OP; Santoro MM; Ngoufack ES; Eyongetah M; Palmer D; Fokunang ET; Fokunang CN; Colizzi V; Perno CF; Ndjolo A
    PLoS One; 2020; 15(7):e0235958. PubMed ID: 32692778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotype-phenotype discordance: the evolution in our understanding HIV-1 drug resistance.
    Zolopa AR
    AIDS; 2003 May; 17(7):1077-8. PubMed ID: 12700459
    [No Abstract]   [Full Text] [Related]  

  • 16. Human immunodeficiency virus type 1 (HIV-1) genotyping in Rio de Janeiro, Brazil: assessing subtype and drug-resistance associated mutations in HIV-1 infected individuals failing highly active antiretroviral therapy.
    Couto-Fernandez JC; Silva-de-Jesus C; Veloso VG; Rachid M; Gracie RS; Chequer-Fernandez SL; Oliveira SM; Arakaki-Sanchez D; Chequer PJ; Morgado MG
    Mem Inst Oswaldo Cruz; 2005 Feb; 100(1):73-8. PubMed ID: 15867968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France.
    Descamps D; Chaix ML; Montes B; Pakianather S; Charpentier C; Storto A; Barin F; Dos Santos G; Krivine A; Delaugerre C; Izopet J; Marcelin AG; Maillard A; Morand-Joubert L; Pallier C; Plantier JC; Tamalet C; Cottalorda J; Desbois D; Calvez V; Brun-Vezinet F; Masquelier B; Costagliola D;
    J Antimicrob Chemother; 2010 Dec; 65(12):2620-7. PubMed ID: 20965891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revisiting the concept of a genetic barrier to resistance.
    Rusconi S
    J HIV Ther; 2006 Dec; 11(4):81-3. PubMed ID: 17578211
    [No Abstract]   [Full Text] [Related]  

  • 19. Are all subtypes created equal? The effectiveness of antiretroviral therapy against non-subtype B HIV-1.
    Kosakovsky Pond SL; Smith DM
    Clin Infect Dis; 2009 May; 48(9):1306-9. PubMed ID: 19331584
    [No Abstract]   [Full Text] [Related]  

  • 20. HIV-1 evolution in relation to molecular epidemiology and antiretroviral resistance.
    Skar H; Hedskog C; Albert J
    Ann N Y Acad Sci; 2011 Aug; 1230():108-18. PubMed ID: 21824168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.